These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 707989)

  • 41. [Histocompatibility patterns in multiple sclerosis. Findings of an epidemiological study (author's transl)].
    Poser S; Ritter G; Bauer HJ; Kuwert EK; Höher PG; Grosse-Wilde H; Hierholzer E
    Nervenarzt; 1981 Jun; 52(6):326-8. PubMed ID: 6973699
    [No Abstract]   [Full Text] [Related]  

  • 42. The contribution of HLA to multiple sclerosis susceptibility in Sardinian affected sibling pairs.
    Marrosu MG; Fadda E; Mancosu C; Lai M; Cocco E; Pugliatti M
    Ann Neurol; 2000 Mar; 47(3):411-2. PubMed ID: 10716270
    [No Abstract]   [Full Text] [Related]  

  • 43. Distribution of HLA-SB antigens in multiple sclerosis.
    Moen T; Stien R; Bratlie A; Bondevik E
    Tissue Antigens; 1984 Aug; 24(2):126-7. PubMed ID: 6593898
    [No Abstract]   [Full Text] [Related]  

  • 44. Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF.
    Stendahl-Brodin L; Link H; Möller E; Norrby E
    Acta Neurol Scand; 1979 Jun; 59(6):297-308. PubMed ID: 90443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA and the immune response to measles in multiple sclerosis.
    Myers LW; Ellison GW; Fewster ME; Terasaki P; Opelz G
    Neurology; 1976 Jun; 26(6 PT 2):54-5. PubMed ID: 944896
    [No Abstract]   [Full Text] [Related]  

  • 46. HLA-linked and unlinked determinants of multiple sclerosis.
    Ho HZ; Tiwari JL; Haile RW; Terasaki PI; Morton NE
    Immunogenetics; 1982; 15(5):509-17. PubMed ID: 6179862
    [No Abstract]   [Full Text] [Related]  

  • 47. Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease.
    Kinnunen E; Koskimies S; Lagerstedt A; Wikström J
    J Neurol Sci; 1984 Aug; 65(2):147-55. PubMed ID: 6592288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA-B12 antigen and multiple sclerosis in a Spanish population (Canary Islands).
    Gantes M; González T
    Tissue Antigens; 1983 Aug; 22(2):172-3. PubMed ID: 6623453
    [No Abstract]   [Full Text] [Related]  

  • 49. The major histocompatibility system, HLA, and multiple sclerosis.
    Jersild C
    Acta Neurol Scand Suppl; 1977; 63():17-21. PubMed ID: 66848
    [No Abstract]   [Full Text] [Related]  

  • 50. Histocompatibility (HL-A) factors in familial multiple sclerosis. Is multiple sclerosis susceptibility inherited via the HL-A chromosome?
    Drachman DA; Davison WC; Mittal KK
    Arch Neurol; 1976 Jun; 33(6):406-13. PubMed ID: 938264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
    Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E
    Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [HLA and multiple sclerosis. Studies of a spanish population].
    Uría DF
    Rev Neurol; 2000 Dec 1-15; 31(11):1066-70. PubMed ID: 11190875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased frequency of HLA--DRw2 and DRw3 in multiple sclerosis.
    de Moerloose P; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
    Tissue Antigens; 1979 May; 13(5):357-60. PubMed ID: 91212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Multiple sclerosis and psoriasis].
    Cendrowski W
    Wiad Lek; 1989 May; 42(9):575-8. PubMed ID: 2629326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA typing and T-cell subpopulations in multiple sclerosis.
    Zaffaroni M; Di Falco M; Ghezzi A; Rizzolo L; Veneroni G; Marforio S
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1465. PubMed ID: 2976813
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression.
    Duquette P; Décary F; Pleines J; Boivin D; Lamoureux G; Cosgrove JB; Lapierre Y
    Can J Neurol Sci; 1985 May; 12(2):106-10. PubMed ID: 3860275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HL-A determinants and familial multiple sclerosis: HL-A typing of 13 families with at least two affected members.
    Hens L; Carton H
    Tissue Antigens; 1978 Jan; 11(1):75-80. PubMed ID: 75592
    [No Abstract]   [Full Text] [Related]  

  • 58. [HLA-DRW antigens and multiple sclerosis].
    De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypocomplementaemic and normocomplementaemic multiple sclerosis. Genetic determinism and association with specific HLA determinants (B18 and B7).
    Trouillas P; Betuel H
    J Neurol Sci; 1977 Jul; 32(3):425-35. PubMed ID: 886365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunogenetics of multiple sclerosis].
    Clanet M; Cambon-Thomsen A; Rascol A
    Pathol Biol (Paris); 1987 Mar; 35(3):299-302. PubMed ID: 3295695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.